4 Results for "

Sodium 4-phenylbutyrate

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Sodium 4-phenylbutyrate" in MCE Product Catalog:

262
262 Cited Publications
Cat. No.: HY-15654
CAS No.: 1716-12-7
Purity:  99.86%
Synonyms: 4-PBA Sodium; 4-Phenylbutyric acid Sodium; Benzenebutyric acid Sodium
Target:  

HDAC Autophagy Apoptosis

Research Areas:  

Cancer

Sodium 4-phenylbutyrate (4-PBA sodium) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, used in cancer and infection research .
loading...
    loading...
Cat. No.: HY-15654S
CAS No.: 1392208-11-5
Purity:  99.85%
Synonyms: 4-PBA-d11 Sodium; 4-Phenylbutyric acid-d11 Sodium; Benzenebutyric acid-d11 Sodium
Phenylbutyrate-d11 (sodium) is deuterium labeled Sodium 4-phenylbutyrate. Sodium 4-phenylbutyrate (4-PBA sodium) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, used in cancer and infection research .
loading...
    loading...
Cat. No.: HY-15654R
CAS No.: 1716-12-7
Synonyms: 4-PBA Sodium (Standard); 4-Phenylbutyric acid Sodium (Standard); Benzenebutyric acid Sodium (Standard)
Research Areas:  

Cancer

Sodium 4-phenylbutyrate (Standard) is the analytical standard of Sodium 4-phenylbutyrate. This product is intended for research and analytical applications. Sodium 4-phenylbutyrate (4-PBA sodium) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, used in cancer and infection research .
loading...
    loading...
Cat. No.: HY-179418
Target:  

Apoptosis

Research Areas:  

Cancer

Ceritinib-platinum(IV)-4-phenylbutyrate (complex 7) is a Ceritinib (HY-15656)-conjugated Platinum(IV) prodrug with anticancer activity. Ceritinib-platinum(IV)-4-phenylbutyrate induces S-phase arrest, DNA damage responses, and apoptosis. Ceritinib-platinum(IV)-4-phenylbutyrate combines cytotoxicity with immune and anti-invasive activation in cancer cell models. Ceritinib-platinum(IV)-4-phenylbutyrate can be used for cancer research, such as non-small cell lung cancer (NSCLC) .
loading...
    loading...